The Neuroethics of Biomarkers: What the Development of Bioprediction Means for Moral Responsibility, Justice, and the Nature of Mental Disorder
0
0
Author Description
Neuroscientists Are Mining Nucleic Acids, Fluids, And Brain Images For Biomarkers Of Risk Of Brain Disorders. This Book Brings Clarity To Several Debates On The Neuroethics Of Biomarkers By Arguing For The Abandonment Of A Categorical Concept Of Disorder (sick Vs. Well) And The Adoption Of An Explicitly Probabilistic One. The Biomedical Promise Of Biomarkers -- Bioprediction Of Brain Disorder: Definitions And Scope -- There Is More Light Here: Re-illuminating The Categories Of Mental -- The Probability Dysfunction -- The Practical Ethics Of Predictive Markers In Diagnosis: Can Risk Banding Address The Ethical Controversy Surrounding Psychosis Risk Syndrome And Preclinical Alzheimer's Disease? -- Enhanced Responsibility: Foreseeability And New Obligations To Others -- Reduced Responsibility: Distinguishing Conditions In Which Biomarkers Properly Reduce Legal Responsibility -- Bioprediction And Priority -- Conclusion By Matthew L. Baum. Includes Bibliographical References And Index.
Menrva's Summary
THE THESIS
This book investigates how the emergence of biomarker-based bioprediction necessitates a fundamental shift in our understanding of moral responsibility, justice, and the classification of mental disorders. Matthew L. Baum, a scholar in the field of neuroethics, utilizes current advancements in neuroscience and diagnostic technology to challenge the traditional binary distinction between health and illness. He argues that the medical community must transition toward an explicitly probabilistic framework to better address the ethical complexities inherent in predicting brain disorders.
THE SCOPE MAP
What You Will Find
- Analysis of biomarker applications in nucleic acids, bodily fluids, and neuroimaging.
- A proposed shift from categorical disorder classification to a probabilistic model.
- Ethical evaluation of risk banding in conditions like psychosis risk syndrome and preclinical Alzheimer's disease.
- Legal and moral frameworks regarding foreseeability and individual responsibility.
Scope Limits
- The text does not provide a comprehensive clinical guide for the diagnosis of specific neurological conditions.
- It does not offer a definitive legal policy but rather explores the theoretical implications for future jurisprudence.
THE AUTHORITY PERSPECTIVE
Experts recognize this work as a significant contribution to the intersection of neurobiology and moral philosophy. Readers frequently note the academic density of the prose, which is intended for professionals and students engaged in bioethics and legal theory.
Page Count:
0
Publication Date:
1900-01-01
Publisher:
Oxford University Press,
ISBN-10:
0190236272
ISBN-13:
9780190236281
Philosophy
Mental Illness
Neuroethics
Biomedical Ethics
Biomarkers
Evidence Based Medicine
Bioethical Issues
Law and ethics
Psychiatry
Bioethics
Neuroscience